Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12-Reference-Cited by-同舟云学术

Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12

Published:2024-03 Issue:1 Volume:32 Page:200758
ISSN:2950-3299
Container-title:Molecular Therapy: Oncology
language:en
Short-container-title:Molecular Therapy: Oncology

Author:

Kurokawa Cheyne,Agrawal Sonia,Mitra Abhisek,Galvani Elena,Burke Shannon,Varshine Ankita,Rothstein Raymond,Schifferli Kevin,Monks Noel R.,Foloppe Johann,Silvestre Nathalie,Quemeneur Eric,Demeusoit Christelle,Kleinpeter Patricia,Sapra Puja,Barrett Carl,Hammond Scott A.,Kelly Elizabeth J.,Laliberte Jason,Durham Nicholas M.,Oberst Michael^ORCID,Broggi Maria A.S.

Funder

AstraZeneca

Publisher

Elsevier BV

Reference43 articles.

1. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer;Galanis;Cancer Res.,2010

2. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma;Kaufman;Ann. Surg Oncol.,2010

3. Constitutive interferon pathway activation in tumors as an efficacy determinant following oncolytic virotherapy;Kurokawa;J. Natl. Cancer Inst.,2018

4. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer;Heo;Nat. Med.,2013

5. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity;Alcamí;J. Virol.,1995

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment;Journal for ImmunoTherapy of Cancer;2024-07